Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

2651-2660 of 4090 results

Catalogue Number:

PX-TA1080

Category:

G

Proteo Genix logo

Edobacomab Biosimilar – Anti-Endotoxin mAb – Research Grade

Target: Endotoxin
Target Alias Name: Edobacomab/E5/XMMEN-0E5/Endotoxin/anti-Endotoxin
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgM-nd
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1081

Category:

G

Proteo Genix logo

Edrecolomab Biosimilar – Anti-EPCAM mAb – Research Grade

Target: EPCAM
Target Alias Name: Edrecolomab/17-1A/EPCAM/anti-EPCAM
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG2a-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1040

Category:

G

Proteo Genix logo

Efalizumab Biosimilar – Anti-ITGAL/ CD11a mAb – Research Grade

Target: ITGAL/ CD11a
Target Alias Name: Efalizumab/hu1124/ITGAL/ CD11a/anti-ITGAL/ CD11a
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1127

Category:

G

Proteo Genix logo

Efungumab Biosimilar – Anti-HSP91 homolog mAb – Research Grade

Target: HSP91 homolog
Target Alias Name: Efungumab/HSP90mab/Mycograb/HSP91 homolog/anti-HSP91 homolog
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: scFv-heavy-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA2061

Category:

G

Proteo Genix logo

Eglatoprutug Biosimilar – Anti-KIT mAb – Research Grade

Target: KIT
Target Alias Name: anti-KIT/ Mast/stem cell growth factor receptor Kit/ p145 c-kit/ Tyrosine-protein kinase Kit/ v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog/ PBT/ Piebald trait protein/ Proto-oncogene c-Kit/ SCFR/ CD117
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1322

Category:

G

Proteo Genix logo

Eldelumab Biosimilar – Anti-CXCL10 mAb – Research Grade

Target: CXCL10
Target Alias Name: Eldelumab/BMS-936557/MDX-1100/CXCL10/anti-CXCL10
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1439

Category:

G

Proteo Genix logo

Elezanumab Biosimilar – Anti-RGMA mAb – Research Grade

Target: RGMA
Target Alias Name: Elezanumab/ABT-555/AE12-1Y-QL(derived from parental mAb AE12-1 and AE12-1Y)/RGMA/anti-RGMA
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1372

Category:

G

Proteo Genix logo

Elgemtumab Biosimilar – Anti-ERBB3 mAb – Research Grade

Target: ERBB3
Target Alias Name: Elgemtumab/LJM716/NVS201010/ERBB3/anti-ERBB3
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1555

Category:

G

Proteo Genix logo

Elipovimab Biosimilar – Anti-HIV-1 gp120 mAb – Research Grade

Target: HIV-1 gp120
Target Alias Name: Elipovimab /GS-HIV/HIV-1 gp120/anti-HIV-1 gp120
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1206

Category:

G

Proteo Genix logo

Elotuzumab Biosimilar – Anti-SLAMF7/ CD319 mAb – Research Grade

Target: SLAMF7/ CD319
Target Alias Name: Elotuzumab/BMS-901608/PDL063/HuLuc63/SLAMF7/ CD319/anti-SLAMF7/ CD319
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo